APA (7th ed.) Citation

Liu, J., Yan, D., Wang, Z., Yang, Y., Zhang, S., Wu, D., . . . Zheng, W. (2020). Tocilizumab in the treatment of severe and refractory parenchymal neuro-Behçet’s syndrome: Case series and literature review. Therapeutic advances in musculoskeletal disease, 12, 1759720X20971908. https://doi.org/10.1177/1759720X20971908

Chicago Style (17th ed.) Citation

Liu, Jinjing, Dong Yan, Zhimian Wang, Yunjiao Yang, Shangzhu Zhang, Di Wu, Lingyi Peng, Zhichun Liu, and Wenjie Zheng. "Tocilizumab in the Treatment of Severe and Refractory Parenchymal Neuro-Behçet’s Syndrome: Case Series and Literature Review." Therapeutic Advances in Musculoskeletal Disease 12 (2020): 1759720X20971908. https://doi.org/10.1177/1759720X20971908.

MLA (9th ed.) Citation

Liu, Jinjing, et al. "Tocilizumab in the Treatment of Severe and Refractory Parenchymal Neuro-Behçet’s Syndrome: Case Series and Literature Review." Therapeutic Advances in Musculoskeletal Disease, vol. 12, 2020, p. 1759720X20971908, https://doi.org/10.1177/1759720X20971908.